会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF DIFFERENT ANEUPLOIDIES IN A SAMPLE
    • 确定样品中不同反应物存在或不存在的方法
    • WO2013015793A1
    • 2013-01-31
    • PCT/US2011/045412
    • 2011-07-26
    • VERINATA HEALTH, INC.RAVA, Richard P.COMSTOCK, David A.RHEES, Brian K.
    • RAVA, Richard P.COMSTOCK, David A.RHEES, Brian K.
    • C12Q1/68
    • C12Q1/6869C12Q1/6806C12Q1/6883C12Q2545/101C12Q2535/122C12Q2531/113
    • ABSTRACT OF THE DISCLOSURE The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the present method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample. Any aneuploidy can be determined from sequencing information that is obtained by sequencing only once the nucleic acids of a test sample.
    • 发明内容本发明提供了一种确定测试样品中感兴趣的序列的拷贝数变异(CNV)的方法,该方法包括已知或怀疑在一个或多个序列的量中不同的核酸的混合物 利益。 该方法包括统计方法,其考虑了由过程相关的染色体间和序列间变异性引起的应变变异性。 该方法适用于确定任何胎儿非整倍性的CNV,以及已知或怀疑与各种医学状况相关的CNV。 可以根据本方法确定的CNV包括染色体1-22,X和Y中的任何一个或多个的三体和单体,其他染色体多糖体,以及任何一个或多个染色体的区段的缺失和/或重复, 其可以通过仅测试一次测试样品的核酸来检测。 任何非整倍体都可以从通过测序一次核酸测试获得的测序信息来确定。
    • 2. 发明申请
    • STORAGE-STABLE GLUCOSE OXIDASE
    • 储存稳定的葡萄糖氧化酶
    • WO2008079227A1
    • 2008-07-03
    • PCT/US2007/025923
    • 2007-12-18
    • DANISCO US, INC., GENENCOR DIVISIONKELEMEN, Bradley, R.LANTZ, Suzanne, E.
    • KELEMEN, Bradley, R.LANTZ, Suzanne, E.
    • C12N9/04A61K8/66
    • C12Y101/03004A61K8/66A61Q19/00C12N9/0006C12N9/96
    • The present invention provides methods and compositions comprising at least one glucose oxidase enzyme, wherein the glucose oxidase has improved storage stability. In some preferred embodiments, the glucose oxidase enzyme is stable after exposure to elevated temperatures. In some alternative preferred embodiments, the glucose oxidase has improved storage stability in liquid formulations. In some particularly preferred embodiments, the present invention provides methods and compositions comprising glucose oxidase(s) obtained from Aspergillus sp. In some more particularly preferred embodiments, the glucose oxidase is obtained from A. niger. The present invention finds use in applications involving cleaning, including personal care applications.
    • 本发明提供包含至少一种葡萄糖氧化酶的方法和组合物,其中葡萄糖氧化酶具有改善的储存稳定性。 在一些优选的实施方案中,葡萄糖氧化酶在暴露于升高的温度之后是稳定的。 在一些替代的优选实施方案中,葡萄糖氧化酶在液体制剂中具有改善的储存稳定性。 在一些特别优选的实施方案中,本发明提供了包含从曲霉属(Aspergillus sp。)获得的葡萄糖氧化酶的方法和组合物。 在一些更特别优选的实施方案中,葡萄糖氧化酶得自黑曲霉。 本发明用于涉及清洁的应用,包括个人护理应用。
    • 4. 发明申请
    • SYSTEM FOR DETERMINING A COPY NUMBER VARIATION
    • 用于确定复制数变化的系统
    • WO2014015319A1
    • 2014-01-23
    • PCT/US2013/051399
    • 2013-07-19
    • VERINATA HEALTH, INC.
    • RAVA, Richard, P.
    • C12Q1/68G06F19/22
    • G06F19/3431C12Q1/6883G06F19/00G06F19/22G06F19/24G16H50/30
    • The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined accord ing to the method include trisomies and monosomies of any one or more of chromosomes 1 -22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.
    • 本发明提供了一种用于确定测试样品中感兴趣的序列的拷贝数变异(CNV)的方法,其包括已知或怀疑在一个或多个感兴趣序列的量上不同的核酸的混合物。 该方法包括统计方法,其考虑了由过程相关的染色体间和序列间变异性引起的应变变异性。 该方法适用于确定任何胎儿非整倍性的CNV,以及已知或怀疑与各种医学状况相关的CNV。 可以根据该方法确定的CNV包括染色体1-22,X和Y中的任何一个或多个的三体和单体,其他染色体多糖,以及任何一个或多个染色体的区段的缺失和/或重复, 其可以通过仅测试一次测试样品的核酸来检测。